Welcome to Sindh Biotechnologist Association

In the realm of ophthalmology, accurate and timely diagnosis is important to ensure optimal patient care. Bacterial keratitis, an infection of the cornea, demands rapid identification for effective treatment. Conventional diagnostic methods have limitations in terms of speed and precision. However, the emergence of Polymerase Chain Reaction (PCR) technology has heralded a new era in ophthalmic diagnostics, offering a revolutionary approach to detecting bacterial keratitis.   Understanding bacterial keratitis: Bacterial keratitis poses a significant threat to ocular health and vision. Caused by bacterial pathogens, this condition can lead to corneal damage and even blindness if left untreated. Swift and accurate identification of the causative bacteria is crucial to administering appropriate antimicrobial therapy. Traditionally, bacterial keratitis diagnosis relied on clinical observation, microbiological cultures, and staining techniques. While these methods are informative, they

This lecture is presented by our volunteer Abrar Hussain, he is from Karachi Pakistan, and he is covering The escence of research. For video:      for slides:

In the ever-evolving landscape of healthcare, a quiet revolution is underway, and its name is nanomedicine. This remarkable fusion of nanotechnology and medicine is poised to change the way we understand and approach healthcare. Imagine a world where diseases are detected earlier than ever before, treatments are personalized down to the molecular level, and medicines are delivered with pinpoint accuracy. This is the world that nanomedicine promises to create, and its potential to transform diagnostics, treatments, drug delivery, and disease monitoring is nothing short of revolutionary. Nanomedicine operates in the realm of the incredibly small—the nanoscale, where particles measure in billionths of a meter. Nanomedicine is the offspring of two powerful fields: nanotechnology and medicine. Nanotechnology deals with crafting materials and structures at the nanoscale and harnessing their unique properties. When combined with medicine, this synergy opens doors to innovative solutions t

This lecture is presented by our volunteer Sajid Ali Shah, he is from Islamabad, Pakistan, and he is covering The role of CRISPR CAS-9 in the treatment of HIV. for video:  for slides: 

Micro RNAs (miRNAs) are small non-coding RNA molecules that play a pivotal role in regulating gene expression post-transcriptionally. Since their discovery in 1993, miRNAs have been identified as key players in various cellular processes, including development, proliferation, differentiation, apoptosis, and stress response [1] . In recent years, miRNAs have gained significant attention in the field of cancer research due to their involvement in tumorigenesis, metastasis, and treatment resistance. This article delves into the intricate relationship between miRNAs and cancer, highlighting their potential as therapeutic targets and exploring the challenges and opportunities of utilizing miRNA-based therapies. miRNAs function by binding to complementary sequences within the 3' untranslated regions (UTRs) of target mRNAs, leading to mRNA degradation or translational repression. This intricate interaction allows miRNAs to fine-tune the expression of numerous genes, ultimately influe